cetyltrimethylammonium ion has been researched along with Carcinoma, Squamous Cell in 1 studies
Cetrimonium: Cetyltrimethylammonium compound whose salts and derivatives are used primarily as topical antiseptics.
cetyltrimethylammonium ion : A quaternary ammonium ion in which the substituents on nitrogen are one hexadecyl and three methyl groups.
Carcinoma, Squamous Cell: A carcinoma derived from stratified SQUAMOUS EPITHELIAL CELLS. It may also occur in sites where glandular or columnar epithelium is normally present. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yue, CH | 1 |
| Chen, CH | 1 |
| Pan, YR | 1 |
| Chen, YP | 1 |
| Huang, FM | 1 |
| Lee, CJ | 1 |
1 other study available for cetyltrimethylammonium ion and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Cetyltrimethylammonium Bromide Disrupts Mesenchymal Characteristics of Human Tongue Squamous Cell Carcinoma SCC4 Cells Through Modulating Canonical TGF-β/Smad/miR-181b/TIMP3 Signaling Pathway.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cetrimonium; Humans; Signal Transduction; Smad2 Protein; | 2021 |